Spravato® is a Esketamine based nasal spray now approved by the FDA as the first stand-alone therapy for adults with Treatment-Resistant Depression (TRD).
**Our appointment scheduling service is undergoing upgrades, the actual appointment date and time will be finalized by our staff. Once you submit your request, you will be contacted to obtain further information (insurance, etc) and confirm if your selected appointment time is available. Please feel free to contact us for any questions or concerns.
